0.6681
                                            Schlusskurs vom Vortag:
              $0.6974
            Offen:
              $0.6974
            24-Stunden-Volumen:
                307.18K
            Relative Volume:
              0.87
            Marktkapitalisierung:
                $27.92M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-74.56M
            KGV:
              -0.3648
            EPS:
                -1.8316
            Netto-Cashflow:
                $-60.27M
            1W Leistung:
              +6.91%
            1M Leistung:
              +18.27%
            6M Leistung:
                +110.76%
            1J Leistung:
              -33.85%
            Rallybio Corp Stock (RLYB) Company Profile
Firmenname
                  
                      Rallybio Corp
                    
                Sektor
                  Branche
                  Telefon
                  
                      203- 859-3820
                    
                Adresse
                  
                      234 CHURCH STREET, NEW HAVEN
                    
                Vergleichen Sie RLYB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                RLYB
                            
                             
                        Rallybio Corp 
                           | 
                    0.6681 | 29.14M | 0 | -74.56M | -60.27M | -1.8316 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-04-09 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2024-05-15 | Herabstufung | JP Morgan | Overweight → Neutral | 
| 2024-02-07 | Herabstufung | Jefferies | Buy → Hold | 
| 2023-04-17 | Eingeleitet | H.C. Wainwright | Buy | 
| 2023-04-10 | Eingeleitet | Wedbush | Outperform | 
| 2022-12-09 | Eingeleitet | JP Morgan | Overweight | 
| 2022-02-22 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2021-08-23 | Eingeleitet | Cowen | Outperform | 
| 2021-08-23 | Eingeleitet | Evercore ISI | Outperform | 
| 2021-08-23 | Eingeleitet | Jefferies | Buy | 
                    Alle ansehen
                    
                  
                Rallybio Corp Aktie (RLYB) Neueste Nachrichten
How to monitor Rallybio Corporation with trend dashboardsJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Why retail investors favor Rallybio Corporation stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Is Rallybio Corporation trending in predictive chart modelsQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
How Rallybio Corporation stock performs in rising dollar environmentJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Why Rallybio Corporation stock remains on buy listsBull Run & Verified Trade Idea Suggestions - newser.com
Will Rallybio Corporation continue its uptrendShort Setup & Accurate Entry/Exit Alerts - newser.com
Technical signs of recovery in Rallybio CorporationJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
How to build a custom watchlist for Rallybio CorporationMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Will Rallybio Corporation stock beat EPS estimatesGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Can Rallybio Corporation stock hit record highs againJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment - TipRanks
Is Rallybio Corporation stock undervalued vs historical averagesMarket Performance Recap & Fast Entry and Exit Trade Plans - Fundação Cultural do Pará
Is Rallybio Corporation stock reversal real or fakeQuarterly Portfolio Summary & Daily Chart Pattern Signals - newser.com
Why Rallybio Corporation stock attracts global investors2025 Year in Review & Stepwise Entry and Exit Trade Signals - fcp.pa.gov.br
Finanzdaten der Rallybio Corp-Aktie (RLYB)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):